| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OMCL | Common Stock | Award | $0 | +56.3K | +121.43% | $0.00 | 103K | Mar 8, 2025 | Direct | F1 |
| transaction | OMCL | Common Stock | Tax liability | -$174K | -4.7K | -4.58% | $36.99 | 97.9K | Mar 8, 2025 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Reflects performance-based restricted stock units that were previously granted on February 27, 2024, subject to the Company meeting certain stock performance objectives compared to the S&P 1000 Healthcare Index. On March 8, 2025 (the determination date), the Compensation Committee determined the performance criteria was met with respect to 56,268 performance-based restricted stock units (176% of target) of which 25% vested upon the determination date. The remaining performance-based restricted stock units will vest in equal quarterly increments once every three months over a three-year period (on each May 15, August 15, November 15, and February 15, respectively). |
| F2 | Reflects withholding of shares to cover taxes due in connection with the vesting of performance-based restricted stock units |